R

TransCode Therapeutics
D

RNAZ

1.81000
USD
0.07
(4.26%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
459
الربح لكل سهم
-9
العائد الربحي
-
P/E
-0
حجم السوق
30,644,638

العنوان: TransCode Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.